LONDON–(BUSINESS WIRE)–Barclays today announces the appointment of Kieran Whitty as Co-Head of Healthcare EMEA (Europe, Middle East and Africa), working alongside Sid Chhibbar, Co-Head of Healthcare EMEA. This appointment reflects Barclays’ effort to continue its growth in the UK and Continental Europe, which is a key focus for Barclays investment bank. Kieran joins Barclays from … [Read more…]
HELSINKI–(BUSINESS WIRE)–Societal stability, high levels of equality and, among other things, political and civil freedom are frequently highlighted as the key factors contributing to Finland’s status as the world’s happiest country in recent years, as reflected in the World Happiness Report. These are the building blocks of the trust and mutual respect that permeate Finnish … [Read more…]
SEATTLE–(BUSINESS WIRE)–Frazier Healthcare Partners, a Seattle-based, healthcare-focused private capital firm, is pleased to announce a passive, minority investment from Petershill at Goldman Sachs Alternatives (“Petershill”). Terms of the transaction were not disclosed. Founded in 1991, Frazier Healthcare Partners (“Frazier”) has invested in more than 200 companies over 34 years. The firm recently closed its latest … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “CRDMO Market – Global Outlook & Forecast 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The CRDMO Market was valued at USD 196.14 billion in 2023, and is projected to reach USD 328.90 billion by 2029, rising at a CAGR of 9.00%. The CRDMO market is highly competitive, with leading players like Lonza … [Read more…]
Nonproprietary drug name approval marks essential step in FDA approval process CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that the United States Adopted Names (USAN) Council has approved “ateganosine” as the nonproprietary (generic) name for its lead molecule THIO, a telomere-targeting … [Read more…]
LONG BEACH, Calif.–(BUSINESS WIRE)–#CNSresearch–The FDA’s landmark approval of Journavx (suzetrigine)—the first non-opioid pain reliever in over two decades—represents a breakthrough in pain management. This breakthrough underscores the urgent need for effective, safer alternatives to opioid medications, providing hope for millions suffering from acute and chronic pain. Ark Clinical Research, a leading clinical research site in … [Read more…]
Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle BALTIMORE–(BUSINESS WIRE)–Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows … [Read more…]
—Breakthrough Will Support Development of New Circulation Cell Culture System to Enhance Quality and Stability of Manufacturing — TOKYO–(BUSINESS WIRE)–PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as “PHC”), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Kyoko Deguchi), and Cyfuse Biomedical K.K. (Headquarters: Minato-ku, Tokyo; CEO: Shizuka Akieda; hereafter … [Read more…]
TOKYO–(BUSINESS WIRE)–Mirailab Bioscience Inc. (Head office: Chuo-ku, Tokyo, CEO: Megumi Tanaka) has obtained patent rights in China for “Food or beverage for babies and infants, method for improving intestinal environment of baby or infant, and method for enhancing immunity of baby or infant” which had been pending a patent (PCT) international application. Patent Summary Application … [Read more…]
IRVING, Texas–(BUSINESS WIRE)–biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that several members of its Board of Directors, along with CEO Bret Christensen, have made open market purchases of Biote’s common stock, acquiring an aggregate … [Read more…]
